Coronary Artery Bypass Graft Market Size & Growth Forecast 2027–2036, By Segments (Method, Surgical Procedure, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Coronary Artery Bypass Graft Market size stood at USD 21.7 billion in 2026 and is predicted to grow at a 3.33% CAGR from 2027 to 2036, reaching USD 30.11 billion by 2036. The industry revenue for 2027 is assessed at USD 22.31 billion.
Get more details on this report
Request Free Sample ReportCoronary Artery Bypass Graft Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to high surgical volumes, strong cardiac care networks, skilled surgeons, and established referral systems managing complex coronary artery disease cases.
- Asia Pacific is expanding at 10.85% CAGR, driven by improving cardiac surgery access, rising cardiovascular disease burden, and expanding hospital capacity for complex procedures.
Segment Momentum
- On-pump held a 64.66% market share in 2026 due to its ability to provide surgical stability and controlled operating conditions, making it the preferred approach for complex grafting procedures requiring precision and consistency.
- Double Bypass is the fastest-growing procedure segment, gaining traction because it suits patients requiring treatment of two affected coronary vessels while supporting a more targeted revascularization approach.
Market Expansion Drivers
- Increasing coronary artery disease prevalence driving demand for advanced cardiac bypass surgical procedures.
- Rising cardiovascular healthcare burden strengthening hospital investments in cardiac surgical treatment capabilities.
- Expanding minimally invasive cardiac surgery programs improving accessibility to coronary bypass interventions.
Leading Market Participants
- Key players in the coronary artery bypass graft market include Medtronic plc (Ireland), Terumo Corporation (Japan), Getinge AB (Sweden), W. L. Gore & Associates Inc. (United States), B. Braun SE (Germany), Abbott Laboratories (United States), LivaNova plc (United Kingdom), Edwards Lifesciences Corporation (United States), Baxter International Inc. (United States), Teleflex Incorporated (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 21.7 billion
- 2027 Estimated Market Size: USD 22.31 billion.
- Projected Market Size: USD 30.11 billion by 2036
- Growth Forecast: 3.33% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: On-pump (Method) | Triple Bypass (Surgical Procedure) | Hospitals (End-use)
- Emerging Opportunity Segment: Off-pump (Method) | Double Bypass (Surgical Procedure) | Cardiology Centers (End-use)
Market Growth Drivers and Industry Trends
Increasing coronary artery disease prevalence driving demand for advanced cardiac bypass surgical procedures
The growing prevalence of coronary artery disease is increasing the need for effective revascularization procedures among patients with significant arterial blockages and complex cardiovascular conditions. Within the coronary artery bypass graft market, the expanding patient pool is supporting demand for advanced surgical approaches capable of restoring blood flow to the heart when other treatment options may be insufficient. Improvements in surgical techniques, perioperative management, and grafting procedures are further enabling healthcare providers to address increasingly complex cases while maintaining attention to patient safety and procedural outcomes.
Rising cardiovascular healthcare burden strengthening hospital investments in cardiac surgical treatment capabilities
A higher cardiovascular disease burden is encouraging hospitals to strengthen their cardiac care infrastructure, surgical capacity, and specialized clinical expertise. This trend supports the coronary artery bypass graft market by prompting healthcare institutions to invest in operating facilities, cardiac surgical equipment, intensive care capabilities, and multidisciplinary teams required for complex bypass procedures. Greater institutional emphasis on comprehensive cardiovascular treatment is also helping hospitals expand their ability to manage patients requiring surgical revascularization, particularly where advanced cardiac interventions form an important component of their treatment services.
Expanding minimally invasive cardiac surgery programs improving accessibility to coronary bypass interventions
The expansion of minimally invasive cardiac surgery programs is creating opportunities to improve the delivery of bypass procedures through approaches designed to reduce surgical trauma and support patient recovery. In the coronary artery bypass graft market, wider implementation of these programs is encouraging hospitals to develop specialized capabilities, train surgical teams, and adopt techniques that can broaden procedural options for suitable patients. Growing clinical interest in less invasive interventions is also supporting the integration of advanced surgical technologies and refined operative methods within cardiac treatment pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing coronary artery disease prevalence driving demand for advanced cardiac bypass surgical procedures | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Rising cardiovascular healthcare burden strengthening hospital investments in cardiac surgical treatment capabilities | 1.60% | Moderate | North America, Europe | High | Mid Term |
| Expanding minimally invasive cardiac surgery programs improving accessibility to coronary bypass interventions | 1.20% | Moderate | Asia Pacific, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the coronary artery bypass graft market, North America held the largest share in 2026, reflecting well-established cardiovascular care infrastructure, broad availability of advanced surgical facilities, and strong access to specialized cardiac care. The region benefits from established clinical capabilities for managing complex coronary artery disease, supported by advanced diagnostic pathways and sophisticated perioperative care. Continued demand for effective revascularization procedures, alongside improvements in surgical techniques and postoperative management, is sustaining the role of bypass surgery within comprehensive cardiovascular treatment systems.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth as cardiovascular disease management expands alongside improving healthcare infrastructure and greater access to specialized cardiac services. Rising awareness of cardiovascular risk factors and increasing availability of advanced diagnostic and surgical capabilities are supporting earlier identification and treatment of coronary artery disease. Investments in hospital capacity, specialist training, and modern cardiac-care facilities are also helping broaden access to coronary artery bypass procedures, particularly across rapidly developing healthcare systems.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Integrated Surgical CareGermany emphasizes coordinated cardiac surgery supported by specialized cardiovascular centers and standardized treatment pathways. Coronary artery bypass graft procedures benefit from continuous investment in surgical technologies and multidisciplinary patient management practices.
France 🇫🇷
Evidence-Based Cardiac PracticeFrance integrates coronary artery bypass graft procedures within structured cardiovascular treatment pathways emphasizing clinical quality and patient safety. Hospitals continue strengthening specialized cardiac surgery services supported by comprehensive postoperative rehabilitation programs.
Italy 🇮🇹
Hospital Cardiac NetworksItaly relies on established cardiac surgery networks to deliver coronary artery bypass graft procedures across regional healthcare systems. Ongoing focus remains on strengthening surgical capacity, optimizing patient referral pathways, and improving procedural consistency in specialized centers.
Japan 🇯🇵
Aging Cardiac CareJapan aligns coronary artery bypass graft procedures with the growing need for advanced cardiovascular interventions among older patients. Healthcare institutions prioritize surgical precision, postoperative recovery, and long-term management through established cardiac care programs.
South Korea 🇰🇷
Minimally Invasive AdoptionSouth Korea increasingly incorporates minimally invasive approaches alongside conventional coronary artery bypass graft procedures where clinically appropriate. Cardiac centers continue modernizing surgical capabilities to enhance recovery experiences and optimize operating room efficiency.
United States 🇺🇸
Complex Cardiac ProceduresThe U.S. maintains strong demand for coronary artery bypass graft procedures driven by advanced cardiac surgery programs and treatment of complex cardiovascular disease. Healthcare providers continue refining surgical techniques and perioperative care to improve patient outcomes and procedural efficiency.
Segment Leadership and Growth Trends
Coronary Artery Bypass Graft Market Share (%), by Method, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMethod Segment Analysis: On-pump (Largest Segment) vs Off-pump (Fastest-Growing Segment)
On-pump procedures dominated the coronary artery bypass graft market, accounting for a 64.66% share in 2026. Their established clinical use is supported by the ability to maintain circulation and oxygenation through cardiopulmonary bypass while surgeons perform complex coronary revascularization under controlled operating conditions. The approach remains particularly relevant for patients requiring extensive grafting or intricate surgical intervention, where a stabilized surgical field can facilitate precise vessel manipulation. Continued demand for comprehensive treatment of advanced coronary artery disease supports the sustained role of on-pump procedures in cardiac surgery.
Off-pump procedures are the fastest-growing method segment as clinicians and healthcare systems increasingly consider approaches that avoid cardiopulmonary bypass in appropriately selected patients. By performing revascularization on the beating heart, off-pump techniques can reduce reliance on extracorporeal circulation and may offer potential advantages for selected patients with elevated procedural risks. Ongoing improvements in surgical stabilization technologies, physician expertise, and patient-selection strategies are supporting broader consideration of off-pump coronary bypass.
Surgical Procedure Segment Analysis: Triple Bypass (Largest Segment) vs Double Bypass (Fastest-Growing Segment)
The triple bypass segment held the largest share of the coronary artery bypass graft market at 44.24% in 2026. Its leading position reflects the continued need for surgical revascularization in patients with disease affecting multiple coronary vessels. Triple bypass procedures enable surgeons to restore blood flow across several obstructed vessels within a comprehensive treatment strategy, making them relevant for patients with extensive coronary artery disease. The persistent burden of multivessel disease and the need for durable revascularization continue to support demand for procedures involving multiple grafts.
Double bypass is the fastest-growing surgical procedure segment as coronary interventions increasingly emphasize appropriately tailored revascularization based on the extent and location of vessel disease. Double bypass can provide comprehensive treatment for patients requiring grafts to multiple affected vessels while avoiding the greater procedural scope associated with more extensive bypass operations. Advances in cardiac imaging, surgical planning, and individualized treatment selection are supporting greater use of procedure-specific approaches based on patient anatomy and clinical needs.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Method | On-pump, Off-pump | On-pump | Off-pump |
| Surgical Procedure | Single Bypass, Double Bypass, Triple Bypass, Quadruple Bypass | Triple Bypass | Double Bypass |
| End-use | Hospitals, Cardiology Centers, Ambulatory Surgical Centers, Others | Hospitals | Cardiology Centers |
Competitive Landscape and Market Positioning
Top players in the coronary artery bypass graft market:
1. Medtronic plc (Ireland)
2. Terumo Corporation (Japan)
3. Getinge AB (Sweden)
4. W. L. Gore & Associates Inc. (United States)
5. B. Braun SE (Germany)
6. Abbott Laboratories (United States)
7. LivaNova plc (United Kingdom)
8. Edwards Lifesciences Corporation (United States)
9. Baxter International Inc. (United States)
10. Teleflex Incorporated (United States)
The coronary artery bypass graft market is progressing through ongoing innovation in graft materials, minimally invasive procedures, and surgical precision technologies aimed at improving cardiovascular treatment outcomes. Increased focus on faster recovery times and reduced procedural complications is encouraging the adoption of advanced surgical techniques and next-generation biomaterials. Continuous research efforts within the coronary artery bypass graft market are also supporting improvements in long-term graft performance and patient care standards.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Terumo Corporation (Japan) | |||||||
| Getinge AB (Sweden) | |||||||
| W. L. Gore & Associates Inc. (United States) | |||||||
| B. Braun SE (Germany) | |||||||
| Abbott Laboratories (United States) | |||||||
| LivaNova plc (United Kingdom) | |||||||
| Edwards Lifesciences Corporation (United States) | |||||||
| Baxter International Inc. (United States) | |||||||
| Teleflex Incorporated (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Centers for Medicare & Medicaid Services | Feb-26 | The Centers for Medicare & Medicaid Services launched the mandatory Transforming Episode Accountability Model (TEAM). The value-based care framework binds designated hospital systems to structured bundled payment structures for major surgical procedures, including cardiac interventions, driving systemic shifts in operational and reimbursement structures through 2030. |
| Rainfall Health | Feb-26 | Rainfall Health secured USD 15 million in financing to accelerate the deployment of its operational compliance software, engineered specifically to assist healthcare providers navigating the CMS TEAM mandates. The investment addresses growing market demand for optimized cardiovascular and surgical care reimbursement tracking under new government bundled payment models. |
| Medtronic | Jun-25 | Medtronic finalized a strategic collaboration with IRCAD North America to advance specialized training and technological adoption in minimally invasive cardiovascular surgery. The joint medical education initiative targets the co-development of clinical training courses featuring advanced Medtronic instruments to accelerate the adoption of complex revascularization procedures. |
| Mahatma Gandhi Memorial Government Hospital | Jun-25 | Mahatma Gandhi Memorial Government Hospital successfully reinstated its specialized cardiac bypass surgery unit following a three-year operational suspension. The facility reactivation restores vital clinical infrastructure for complex coronary artery bypass graft interventions and significantly scales regional surgical capacity for ischemic heart disease patients. |
| Terumo Health Outcomes | Dec-24 | Terumo Health Outcomes entered into a strategic commercial partnership with Medis Medical Imaging to combine its ePRISM precision medicine platform with Medis' Quantitative Flow Ratio (QFR) imaging technology. The digital integration provides advanced diagnostic accuracy and optimized pre-operative treatment planning for severe coronary artery disease in the United States. |
| Getinge | Nov-24 | Getinge initiated a widespread product recall for its endoscopic vessel harvesting (EVH) systems utilized in coronary artery bypass graft procedures following critical component failure reports. The Food and Drug Administration issued safety alerts, warning clinical institutions of imminent supply chain disruptions and product shortages across the cardiac surgery sector. |
| Doctors Medical Center | Aug-24 | Doctors Medical Center successfully completed a multi-graft robotic-assisted coronary artery bypass graft (CABG) surgical procedure utilizing the da Vinci surgical system. The milestone demonstrates a critical expansion of robotic capabilities, advancing standard procedures beyond less complex single-graft interventions into highly intricate multi-vessel revascularizations. |
| Transonic Systems Inc. | Aug-24 | Transonic Systems Inc. established an exclusive global distribution agreement with ADInstruments to secure the commercial supply of its life science volume flow measurement products. The partnership ensures long-term supply chain stability and specialized technical support for global institutions conducting critical preclinical biomedical and cardiovascular flow studies. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Coronary Artery Bypass Graft Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Graft Material | Saphenous Vein Grafts, Internal Mammary Artery Grafts, Radial Artery Grafts, Other Arterial Grafts |
| Patient Risk Category | Low-Risk Patients, Intermediate-Risk Patients, High-Risk Patients |
| Hospital Ownership | Public/Government Hospitals, Private Hospitals, Non-Profit Hospitals |
Coronary Artery Bypass Graft Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Cardiac Surgery Capacity Expansion Outlook |
|
| Coronary Revascularization Treatment Pathway Analysis |
|
| Advanced Surgical Technologies Adoption Landscape |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the coronary artery bypass graft market generate?
What is the forecasted size of the coronary artery bypass graft industry?
How is the rising prevalence of complex coronary artery disease influencing demand in the coronary artery bypass graft market?
Why are hospitals increasing investment in cardiac surgical capabilities for coronary bypass procedures?
Why does the On-pump method lead the coronary artery bypass graft market?
Which surgical procedure segment is growing the fastest in the coronary artery bypass graft market?
Why does North America lead the coronary artery bypass graft market?
What is driving growth in Asia Pacific’s coronary artery bypass graft market?
What are the prominent companies operating in the coronary artery bypass graft landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization